Paper5334595
Inactivated Mycoplasma pneumoniae vaccine. Evaluation in volunteers.
Smith CB and 2 others. JAMA, 1967. Cited by 76 papers, by iCite.
Cite this record
ConductScience Library. Inactivated Mycoplasma pneumoniae vaccine. Evaluation in volunteers. Papers, record 5334595. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/5334595
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibody Formation | Major topic |
| Bacterial Vaccines | Major topic |
| Mycoplasma | Major topic |
| Pneumonia | Major topic |
| Adult | |
| Clinical Trials as Topic | |
| Erythromycin | |
| Evaluation Studies as Topic | |
| Humans | |
| Male | |
| Placebos | |
| Respiratory Tract Diseases | |
| Tetracycline |
Source PubMed
Cited by27
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 76 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41438744 | Development of human mycoplasma vaccines: navigating the IL-17A paradox. | Front Immunol | 2025 | https://conductscience.org/library/papers/41438744 | PubMed |
| 41012172 | Adjuvant Mucosal Strategies Confer Safe and Effective Immunity Against Mycoplasma pneumoniae and Overcome Vaccine-Associated Enhanced Lung Pathology. | Vaccines (Basel) | 2025 | https://conductscience.org/library/papers/41012172 | PubMed |
| 40650312 | An mRNA Vaccine Targeting the C-Terminal Region of P1 Protein Induces an Immune Response and Protects Against Mycoplasma pneumoniae. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40650312 | PubMed |
| 39291404 | Research of recombinant influenza A virus as a vector for Mycoplasma pneumoniae P1a and P30a. | Immun Inflamm Dis | 2024 | https://conductscience.org/library/papers/39291404 | PubMed |
| 36310317 | B cells oppose Mycoplasma pneumoniae vaccine enhanced disease and limit bacterial colonization of the lungs. | NPJ Vaccines | 2022 | https://conductscience.org/library/papers/36310317 | PubMed |
| 35906257 | Vaccination with Mycoplasma pneumoniae membrane lipoproteins induces IL-17A driven neutrophilia that mediates Vaccine-Enhanced Disease. | NPJ Vaccines | 2022 | https://conductscience.org/library/papers/35906257 | PubMed |
| 34481867 | SARS-CoV-2, Zika viruses and mycoplasma: Structure, pathogenesis and some treatment options in these emerging viral and bacterial infectious diseases. | Biochim Biophys Acta Mol Basis Dis | 2021 | https://conductscience.org/library/papers/34481867 | PubMed |
| 33503845 | Mycoplasma pneumoniae Infections: Pathogenesis and Vaccine Development. | Pathogens | 2021 | https://conductscience.org/library/papers/33503845 | PubMed |
| 33195997 | Applying Immune Instincts and Maternal Intelligence from Comparative Microbiology to COVID-19. | SN Compr Clin Med | 2020 | https://conductscience.org/library/papers/33195997 | PubMed |
| 32285942 | Defining protective epitopes for COVID-19 vaccination models. | J Med Virol | 2020 | https://conductscience.org/library/papers/32285942 | PubMed |
| 32284882 | Lipid moieties of Mycoplasma pneumoniae lipoproteins are the causative factor of vaccine-enhanced disease. | NPJ Vaccines | 2020 | https://conductscience.org/library/papers/32284882 | PubMed |
| 30396892 | Antibodies to Protein but Not Glycolipid Structures Are Important for Host Defense against Mycoplasma pneumoniae. | Infect Immun | 2019 | https://conductscience.org/library/papers/30396892 | PubMed |
| 23001692 | Mycoplasma pneumoniae extract induces an IL-17-associated inflammatory reaction in murine lung: implication for mycoplasmal pneumonia. | Inflammation | 2013 | https://conductscience.org/library/papers/23001692 | PubMed |
| 22252865 | Vaccination of BALB/c mice with an avirulent Mycoplasma pneumoniae P30 mutant results in disease exacerbation upon challenge with a virulent strain. | Infect Immun | 2012 | https://conductscience.org/library/papers/22252865 | PubMed |
| 16557776 | Protective Effect of Vaccines in Experimental Mycoplasma pneumoniae Disease. | Infect Immun | 1970 | https://conductscience.org/library/papers/16557776 | PubMed |
| 10341174 | Respiratory diseases among U.S. military personnel: countering emerging threats. | Emerg Infect Dis | 1999 | https://conductscience.org/library/papers/10341174 | PubMed |
| 8244491 | Mycoplasma infections of the human respiratory tract. | Indian J Pediatr | 1993 | https://conductscience.org/library/papers/8244491 | PubMed |
| 8112834 | Immunoblot analyses of chimpanzee sera after infection and after immunization and challenge with Mycoplasma pneumoniae. | Infect Immun | 1994 | https://conductscience.org/library/papers/8112834 | PubMed |
| 6779413 | Exfoliation of respiratory epithelium in hamster tracheal organ cultures infected with Mycoplasma pneumoniae. | Virchows Arch A Pathol Anat Histol | 1980 | https://conductscience.org/library/papers/6779413 | PubMed |
| 5359607 | Characteristics of virulent, attenuated, and avirulent Mycoplasma pneumoniae strains. | J Bacteriol | 1969 | https://conductscience.org/library/papers/5359607 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/5334595
GET https://conductscience.org/api/papers/v1/5334595/cited_by?page=2